Key Market Indicators
The coverage of HIV/AIDS treatment in Bangladesh is expected to reach 31% of people living with HIV by 2026, up from 25% in 2021. This represents an average annual growth rate of 3.6%. Since 2011, the Bangladeshi market has grown by 10.8 points each year. In 2021, Bangladesh came in 129th place, with the Republic of the Congo taking the lead with 25%. Cape Verde, Latvia and Zimbabwe followed in second, third and fourth place respectively. The prevalence of HIV/AIDS in Bangladesh is set to reach 611 people aged 0-14 by 2026, up from 548 in 2021. This is an average annual growth rate of 1.7%. Since 1995, the demand for HIV/AIDS in Bangladesh has grown by 1.9% each year. In 2021, Bangladesh was ranked 72nd, with Belarus ahead at 548 people aged 0-14. Nigeria, Mozambique and Tanzania were placed second, third and fourth, respectively.
